demonstrated that small molecule epigenetic inhibitors modulate key cellular signaling pathways, including NF-κB, TGFβ and WNT signaling, as well as major metabolic pathways, such as fatty acid metabolism and the TCA cycle, ultimately reducing platinum resistance in ovarian cancer cell lines (54). This evidence concerns the gene TGFB1 and ovarian carcinoma.